Abstract
The capacity to modulate inflammatory response and the metabolism of fatty acids of polyunsaturated fatty acids omega-3 (PUFA n-3) have shown benefits in controlling steatosis and the production of metabolic and inflammatory responses markers in NAFLD/NASH. The mechanisms associated with these benefits remain poorly understood. This study aims to evaluate the metabolomic profile of patien…